OncoCyte Corp
OncoCyte Corporation operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test tha… Read more
OncoCyte Corp (OCX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: -0.573x
Based on the latest financial reports, OncoCyte Corp (OCX) has a cash flow conversion efficiency ratio of -0.573x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.86 Million) by net assets ($10.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
OncoCyte Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how OncoCyte Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
OncoCyte Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OncoCyte Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atlan Holdings Bhd
KLSE:7048
|
0.149x |
|
Zaklad Budowy Maszyn ZREMB-CHOJNICE S.A.
WAR:ZRE
|
0.014x |
|
Kolon Globalco
KO:003070
|
-0.036x |
|
Tay Ninh Rubber JSC
VN:TRC
|
N/A |
|
EDAG Engineering Group AG
XETRA:ED4
|
0.052x |
|
Kuya Silver Corporation
OTCQB:KUYAF
|
-0.025x |
|
Barinthus Biotherapeutics plc
NASDAQ:BRNS
|
-0.127x |
|
Dr Peng Telecom and Media Group Co Ltd
SHG:600804
|
-0.566x |
Annual Cash Flow Conversion Efficiency for OncoCyte Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of OncoCyte Corp from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-12.27 Million | $-20.71 Million | 1.688x | +285.17% |
| 2023-12-31 | $25.59 Million | $-23.32 Million | -0.911x | +31.42% |
| 2022-12-31 | $34.29 Million | $-45.57 Million | -1.329x | -141.12% |
| 2021-12-31 | $65.22 Million | $-35.94 Million | -0.551x | +28.97% |
| 2020-12-31 | $33.48 Million | $-25.98 Million | -0.776x | -21.37% |
| 2019-12-31 | $30.84 Million | $-19.71 Million | -0.639x | +81.21% |
| 2018-12-31 | $3.42 Million | $-11.65 Million | -3.403x | -11.95% |
| 2017-12-31 | $4.40 Million | $-13.38 Million | -3.040x | -298.57% |
| 2016-12-31 | $9.86 Million | $-7.52 Million | -0.763x | -87.88% |
| 2015-12-31 | $10.42 Million | $-4.23 Million | -0.406x | -137.46% |
| 2014-12-31 | $-1.07 Million | $-1.16 Million | 1.084x | +651.82% |
| 2013-12-31 | $3.62 Million | $-710.00K | -0.196x | -- |